Four Steps to Linking Clinical Trial and Real-World Data
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Lab Data in Clinical Research: 4 Ways It Drives Better Outcomes While most life sciences teams know...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
As we honor our military service members this Veterans Day, we take time to reflect on how we can...
In a recent report, the Centers for Disease Control and Prevention (CDC) found that four out of...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
HealthVerity’s journey from an unknown startup to a major disrupter in the Healthcare industry ...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
Exploring the impacts and benefits of a real-world data strategy for long-term care insurance...
When our client, a global pharmaceutical company, set out to better understand long COVID pathways, they had a central question to answer:how much of the long COVID population are we missing if we rely on diagnosis codes alone?